Literature DB >> 8480084

Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos.

G M Tiboni1.   

Abstract

The teratogenic potential of the novel bis-triazole antifungal agent fluconazole (F) was investigated on mouse embryos during early organogenesis using the whole-embryo culture system. Early somite stage embryos (4-5 somites) were continuously cultured for 48 hours in rat serum added with 0, 25, 50 or 75 micrograms/ml of F. Doses of 50 and 75 micrograms/ml of F significantly (p < 0.001) impaired morphogenesis, resulting in a 83.3% and 91.6% of embryos showing second branchial arch anomalies, respectively. These findings demonstrate that F induces second branchial arch anomalies in cultured mouse conceptuses. Furthermore, these results may suggest an useful model for the study of arches-derived malformations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8480084

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  10 in total

1.  In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol.

Authors:  E Menegola; M L Broccia; F Di Renzo; M Prati; E Giavini
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

2.  Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.

Authors:  Katelyn A Pastick; Elizabeth Nalintya; Lillian Tugume; Kenneth Ssebambulidde; Nicole Stephens; Emily E Evans; Jane Frances Ndyetukira; Edwin Nuwagira; Caleb Skipper; Conrad Muzoora; David B Meya; Joshua Rhein; David R Boulware; Radha Rajasingham
Journal:  Med Mycol       Date:  2020-04-01       Impact factor: 4.076

Review 3.  Use of antifungal drugs in pregnancy: a focus on safety.

Authors:  J D Sobel
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

4.  Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.

Authors:  Anick Bérard; Odile Sheehy; Jin-Ping Zhao; Jessica Gorgui; Sasha Bernatsky; Cristiano Soares de Moura; Michal Abrahamowicz
Journal:  CMAJ       Date:  2019-02-19       Impact factor: 8.262

5.  Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.

Authors:  Robert S Foti; Philippe Diaz; Dominique Douguet
Journal:  J Enzyme Inhib Med Chem       Date:  2016-07-17       Impact factor: 5.051

6.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

7.  Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.

Authors:  Dionissios Neofytos; Edina Avdic; Anna-Pelagia Magiorakos
Journal:  Drug Healthc Patient Saf       Date:  2010-04-20

8.  Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study.

Authors:  Yanmin Zhu; Brian T Bateman; Kathryn J Gray; Sonia Hernandez-Diaz; Helen Mogun; Loreen Straub; Krista F Huybrechts
Journal:  BMJ       Date:  2020-05-20

9.  Cytotoxic and Genotoxic Effects of Fluconazole on African Green Monkey Kidney (Vero) Cell Line.

Authors:  Regianne Maciel Dos Santos Correa; Tatiane Cristina Mota; Adriana Costa Guimarães; Laís Teixeira Bonfim; Rommel Rodriguez Burbano; Marcelo de Oliveira Bahia
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

10.  Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation.

Authors:  Reuben Kiggundu; Joshua Rhein; David B Meya; David R Boulware; Nathan C Bahr
Journal:  Med Mycol Case Rep       Date:  2014-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.